Skip to main content

Part of the book series: Basic Life Sciences ((BLSC))

  • 127 Accesses

Abstract

Clinicians and research scientists alike have for years utilized the immune response to generate antibodies to probe physiologic and biochemical systems. Polyclonal antibody found in the course of the humoral response to an antigen may detect, quantify, and localize small amounts of material in complex mixtures. Were it not for the heterogeneity and unpredictability of the immune reponse, immunologic assays might have had an even greater application. With the introduction of somatic cell fusion most of the problems associated with polyclonal antisera and their application to basic and clinical questions are likely to be overcome.

This work was supported by NIH grant HL-19529, NCI grant //CA-17393, USPH grant AM-16791, and the Specialized Center for Research in Ischemic Heart Disease grant #HL-26215.

Dr. Mudgett-Hunter is a recipient of Established Investigator Award #79-189 from the American Heart Association.

Dr. Budzik is a recipient of the Charles A. King Trust Fellowship, Medical Research Foundation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kohler, G., Milstein, C 1975. Continuous cultures of fused cells secreting antibody of pre-defined specificity. Nature 256: 495–497.

    Article  Google Scholar 

  2. Yelton, D. E., Scharff, M. D 1981. Monoclonal antibodies: A powerful new tool in biology and medicine. Ann. Rev. Biochem. 50: 657–680.

    Article  Google Scholar 

  3. Hoffman, B. F., J. T. Bigger, Jr. 1980. Digitalis and allied cardiac glycosides. In The Pharmacological Basis of Therapeutics. 6th edition. ( A. G. Gilman, Y. S. Goodman, and A. Gilman, Eds.) MacMillan, New York. pp 729–760.

    Google Scholar 

  4. Smith, T. W., E. Haber 1973. Digitalis. New Engl. J. Med. 289:945, 1010, 1063, 1125.

    Google Scholar 

  5. Smith, T. W., V. P. Butler, Jr., E. Haber. 1969. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. New Engl. J. Med. 281: 1212–1216.

    Google Scholar 

  6. Mudgett-Hunter, M., M. N. Margolies, A. Ju, E. Haber. 1982. High affinity monoclonal antibodies to the cardiac glycoside digoxin. J. Immunol., (in press).

    Google Scholar 

  7. Smith, T. W 1972. Ouabain-specific antibodies: Immunochemical properties and reversal of NA+, K+-activated adenosine triphosphatase inhibition. J. Clin. Invest. 51: 1583–1593.

    Article  Google Scholar 

  8. Nisonoff, A., Pressman, D 1958. Heterogeneity and average combining constants of antibodies from individual rabbits. J. Immunol. 80: 417–428.

    Google Scholar 

  9. Novotny, J., Mudgett-Hunter, M., Haber, E., Margolies, M. N 1981. Primary structure of a mouse antidigoxin hybridoma antibody. Fed. Proc. 40: 1098.

    Google Scholar 

  10. Schwartz, A., G. E. Lindenmayer, J. C. Allen. 1975. The sodium-potassium adenosine triphosphatase: Pharmacological, physiological and biochemical aspects. Pharmacol. Rev. 27: 3–134.

    Google Scholar 

  11. Smith, T. W., E. Haber, L. Yeatman, V. P. Butler, Jr. 1976. Reversal of advanced digoxin intoxication with Fab fragments of digoxinspecific antibodies. New Eng. J. Med. 294: 797–800.

    Google Scholar 

  12. Burchiel, S. W., B. A. Khaw, B. G. Rhodes, T. W. Smith, E. Haber. 1981. Immunopharmacokinetics and radiolabeled antibodies and their fragments. In Tumor Imaging: Radioimmunochemical Detection of Cancer. Edited by S. W. Burchiel, B. A. Rhodes, and B. Friedman. Masson, New York.

    Google Scholar 

  13. Margolies, M. N., M. Mudgett-Hunter, J. Novotny, E. Haber 1981. Monoclonal antibodies directed against the cardiac glycoside digoxin. In Monoclonal Antibodies and T Cell Hybridomas. ( G. Hammerling, U. Hammerling, and J.F. Kearney, Eds.) Elsevier, New York.

    Google Scholar 

  14. Jost, A 1946. Sur la différenciation sexuelle de l’embryon de lapin experiences de paraboise. CR Soc. Biol. 140: 463–464.

    Google Scholar 

  15. Jost, A 1946. Sur la différenciation sexuelle de l’embryon de lapin remarques au sujet de certaines operations chirurgical. CR Soc. Biol. 140: 460–462.

    Google Scholar 

  16. Jost, A 1947. Sur les derives mulleriens d’embryons de lapin des deus sexes castres a 21 jours. CR Soc. Biol. 141: 135–136.

    Google Scholar 

  17. Donahoe, P. K., D. A. Swann, A. Hayashi, M. D. Sullivan. 1979. Mullerian duct regression in the embryo correlated with cytotoxic activity against a human ovarian cancer. Science 205: 913–915.

    Article  Google Scholar 

  18. Donahoe, P. K., A. F. Fuller, Jr., R. E. Scully, S. R. Guy, G. P. Budzik. 1981. Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice. Ann. Surg. 194: 472–480.

    Google Scholar 

  19. Fuller, A. F. Jr., S. R. Guy, G. P. Budzik, P. K. Donahoe. 1982. Mullerian inhibiting substance inhibits colony growth of a human ovarian cancer cell line. J. Clin. Endo. Metab. 54: 1051–1055.

    Google Scholar 

  20. Donahoe, P. K., G. P. Budzik, R. L. Trelstad, M. Mudgett-Hunter, A.F. Fuller, Jr., J. M. Hutson, H. Ikawa, A. Hayashi, D.T. MacLaughlin. 1982. Mullerian inhibiting substance: An update. In Recent Progress in Hormone Research, Vo. 38. ( R.O. Greep, Ed.), New York: Academic Press, pp 279–330.

    Google Scholar 

  21. Mudgett-Hunter, M., G. P. Budzik, M. Sullivan, P. K. Donahoe. 1982. Monoclonal antibody to mullerian inhibiting substance. J. Immunol. 128: 1327–1333.

    Google Scholar 

  22. Donahoe, P. K., Y. Ito, S. Marfatia, W. H. Hendren 1977. A graded organ culture assay for the detection of Mullerian inhibiting substance. J. Surg. Res. 23: 141–148.

    Google Scholar 

  23. Finger, J. M., Choo, K. H. 1981. Double-label reductive methylation of tissue proteins for precision two-dimensional polyacrylamide-gel electrophoretic analysis. Biochem. J. 193: 371–374.

    Google Scholar 

  24. Blanchard, M., Josso, N. 1974. Sources of the anti- Mullerian hormone synthesized by the fetal testis: Mullerian inhibiting activity of fetal bovine Sertoli cells in tissue culture. Ped. Res. 8: 968–971.

    Article  Google Scholar 

  25. Price, J. M 1979. The secretion of Mullerian inhibiting substance by culture isolated Sertoli cells of the neonatal calf. Am. J. Anat. 156: 147–157.

    Google Scholar 

  26. Pierce, J.G., Parsons, T. F. 1981. Glycoprotein hormones: Structure and function. Ann. Rev. Biochem. 50: 465–495.

    Article  Google Scholar 

  27. Ridgeway, E. C., L. J. Ardisson, M. J. Meskell, Mudgett-Hunter, M 1982. Monoclonal antibody to human thyrotropin. J. Clin. Endo. Metab. 55: 44–48.

    Google Scholar 

  28. Khaw, B. A., G. A. Beller, E. Haber, Smith, T. W 1976. Localization of cardiac myosin-specific antibody in myocardial infarction. J. Clin. Invest. 58: 439–446.

    Article  Google Scholar 

  29. Khaw, B. A., G. A. Beller, Haber, E. 1978. Experimental myco-cardial infarct imaging following intravenous administration of Iodine-131 labeled antibody (Fabf)2 fragments specific for cardiac myosin. Circulation. 57: 743–750.

    Google Scholar 

  30. Khaw, B.A., J.T. Fallon, H.W. Strauss, E. Haber 1980. Myocardial infarct imaging with Indium-111-diethylene triamine pentaacetic acid-anticanine cardiac myosin antibodies. Science. 209: 295–297.

    Article  Google Scholar 

  31. Khaw, B. A., J. T. Fallon, H. Katus, D. Elmaleh, H. W. Strauss, E. Locke, G. M. Pohost, E. Haber 1979. Positron imaging of experimental myocardial infarction with 68Ga-DTPA-antimyosin antibody. Circulation. 59 and 60 (Suppl II): 139.

    Google Scholar 

  32. Khaw, B. A., H. W. Strauss, A. Carvalho, E. Locke, H. K. Gold, E. Haber. Labeling anti-cardiac myosin Fab and human fibrinogen with Technetium-99m. J. Nucl. Med. (submitted for publication).

    Google Scholar 

  33. Wands, J. R., Zurawski, V. R 1981. High affinity monoclonal antibodies to hepatitis B surface antigen produced by somatic cell hybrids. Gastroent. 80: 225–232.

    Google Scholar 

  34. Porter, R. R 1959. The hydrolysis of rabbit gamma-globulin and antibodies with crystalline papain. Biochem. J. 73: 119–126.

    Google Scholar 

  35. Ey, P.L., S. J. Prowse, C. R. Jenkin. 1978. Isolation of pure IGGL, IGG2A and IGG2B immunoglobulins from mouse serum using protein A Sepharose. Immunochem. 15: 429–436.

    Article  Google Scholar 

  36. Krejcarek, G. E., Tucker, K.L 1977. Covalent attachment of chelating groups to macromolecules. Biochem. Biophys. Res. Comm. 77: 582–585.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Plenum Press, New York

About this chapter

Cite this chapter

Mudgett-Hunter, M. et al. (1983). Monoclonal Antibodies as Physiologic Probes. In: Hollaender, A., et al. Basic Biology of New Developments in Biotechnology. Basic Life Sciences. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4460-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4460-5_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4462-9

  • Online ISBN: 978-1-4684-4460-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics